Understanding OUR Cytokine-Based Immunotherapy Candidates Our commitment extends to advancing a robust portfolio of programs aimed toward growing the horizons of cytokine-based immunotherapy, especially for cancers where therapy solutions remain limited. Use the links below to learn more about our portfolio of cytokine-based immunotherapy candidates. Take a look at https://financefeeds.com/itrustcapital-review-features-and-faqs-a-comprehensive-look-into-their-award-winning-copyright-ira-platform-2025/